Co-treatment of PM014 with TGF-β1 induced remarked reduction of the migration of healthy donor fibroblasts (Fig. S8a) and IPF fibroblasts (Fig. S8b) compared with fibroblasts treated with TGF-β1 only, respectively. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.